Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Daily brisk walk could reduce risk of death
(January 19, 2015 - Insidermedicine) From Cambridge - A new ...
(January 19, 2015 - Insidermedicine) From Cambridge - A new report published in the American Journal of Clinical Nutrition finds that taking a brisk walk every day could greatly reduce risk of premature death. Researchers reviewed data on over 330,000 men and women taking part in the European Prospective Investigation into Cancer and Nutrition study. Participants were followed for 12 years. Results showed that the greatest reduction in risk of premature death occurred when they compared physically inactive and moderately inactive people. Researchers estimate that a brisk 20 minute walk every day would bump inactive people into being moderately inactive, and reduce their risk of premature death by as much as 30%
-
HD
Early blood glucose control in type 1 diabetes lengthens life
(January 14, 2015 - Insidermedicine) From Maryland - According to ...
(January 14, 2015 - Insidermedicine) From Maryland - According to research published in JAMA, controlling blood glucose early in a type 1 diabetics life significantly lengthens life. Starting in 1983, researchers studied over 1,400 patients recently diagnosed in with type 1 diabetes. Participants were between 13 and 39 years of age and followed for an average 27 years. Results showed that those who received intensive blood glucose control early in their disease had a 33% reduced incidence of deaths.
-
HD
Better psychosocial experience in youth linked to better health later in life
(January 14, 2015 - Insidermedicine) From Finland - Positive experiences ...
(January 14, 2015 - Insidermedicine) From Finland - Positive experiences in youth may be linked to better heart health later in life, according to research published in Circulation. Researchers studied over 3,500 children between the ages of 3 and 18 years. They measured six factors in the children--socioeconomic status, emotional stability, parental health behaviours, stressful events, self-regulation of behavioural problems and social adjustment--then followed up with the children 27 years later when the participants were 30-45 years old. Results showed favourable psychosocial experiences in childhood was linked to better cardiovascular health in adulthood.
-
HD
Type 1 diabetes patients have shorter lifespan
(January 9, 2015 - Insidermedicine) From Scotland - A new ...
(January 9, 2015 - Insidermedicine) From Scotland - A new report published in JAMA finds that type 1 diabetes patients have a shorter lifespan. Researchers examined a national registry of patients with type 1 diabetes. All told, the study included nearly 25,000 type 1 diabetics aged 20 and older. Results showed that male patients with type 1 diabetes had an average life expectancy loss of nearly 11 years, while female patients lost an average of 13 years.
-
HD
Radiation, hormone therapy combine to prolong life in prostate cancer patients
(January 7, 2014 - Insidermedicine) From Philadelphia - According to ...
(January 7, 2014 - Insidermedicine) From Philadelphia - According to research published in the Journal of Clinical Oncology, radiation in addition to hormone therapy for prostate cancer may lengthen life. Researchers studied over 30,000 men with prostate cancer between 65 and 85 years of age. Participants were followed for an average of seven years. Results showed adding radiation treatment to hormone therapy reduced cancer deaths among those aged 76-85 by nearly 50%, when compared to those who only received hormone therapy.
-
HD
ICU infections raise risk of death
(January 6, 2014 - Insidermedicine) From New York - Infections ...
(January 6, 2014 - Insidermedicine) From New York - Infections in the ICU greatly raise risk of death, according to a report published in the American Journal of Infection Control. Researchers studied the outcomes among over 17,000 elderly patients who had been admitted to hospital, and were followed for an additional five years. Results showed that those who had been admitted to the ICU and developed an infection during their stay were 35% more likely to die within the study period.
-
HD
Healthy lifestyle may help prevent heart disease in most women
(January 6, 2014 - Insidermedicine) From Indiana - A new ...
(January 6, 2014 - Insidermedicine) From Indiana - A new report published in the Journal of the American College of Cardiology finds that a healthy lifestyle may help prevent heart disease in 75% of women. Researchers reviewed data on nearly 70,000 women taking part in a long term study, with follow-up lasting 20 years. The healthy lifestyle habits were: not smoking, normal BMI, 2.5 hours of physical activity a week, watching less than 7 hours of television a week, only one alcoholic drink consumed per day on average, and a healthy diet. Those who followed all 6 were at 92% reduced risk of heart attack and 66% reduced risk of heart disease
-
HD
Cigarettes responsible for 3 in 10 cancer deaths
(January 5, 2015 - Insidermedicine) From Atlanta - A new ...
(January 5, 2015 - Insidermedicine) From Atlanta - A new study published in the Annals of Epidemiology finds that cigarettes are responsible for 3 out of 10 cancer deaths in the United States. Researchers examined data from the National Health Interview Survey and only included deaths from the cancers currently accepted as being related to smoking. The estimate does not include deaths from environmental exposures or other types or tobacco smoke, such as cigars.
-
HD
Obesity fighting potato extract
(January 5, 2015 - Insidermedicine) From Montreal - According to ...
(January 5, 2015 - Insidermedicine) From Montreal - According to a new report published in Molecular Nutrition & Food Research, an extract from potatoes may help in fighting obesity. Mice were fed a diet that would cause weight gain, and on average mice who started out weighing 25 grams, gained an additional 16 grams. Those mice who also received the potato extract however, only gained an additional 7 grams. The extract is high in polyphenols, a compound found in most fruits and vegetables.
-
HD
Hypoglycaemia risk of the pain killer tramadol
(January 2, 2015 - Insidermedicine) From Montreal - According to ...
(January 2, 2015 - Insidermedicine) From Montreal - According to a new report in JAMA Internal Medicine, the opioid pain killer tramadol may raise risk of hypoglycaemia, severe enough to warrant hospitalization. Using data gathered in the UK between 1998 and 2012, researchers analyzed data from over 330,000 patients. Comparing codeine with tramadol for non-cancer pain, tramadol was associated with double the risk of hospitalization for hypoglycaemia.
